JP2003235592A - Organic acid production method - Google Patents
Organic acid production methodInfo
- Publication number
- JP2003235592A JP2003235592A JP2002034825A JP2002034825A JP2003235592A JP 2003235592 A JP2003235592 A JP 2003235592A JP 2002034825 A JP2002034825 A JP 2002034825A JP 2002034825 A JP2002034825 A JP 2002034825A JP 2003235592 A JP2003235592 A JP 2003235592A
- Authority
- JP
- Japan
- Prior art keywords
- organic acid
- producing
- acid
- bacterium
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 150000007524 organic acids Chemical class 0.000 title claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000012258 culturing Methods 0.000 claims abstract description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 20
- 239000008103 glucose Substances 0.000 claims description 20
- 239000001384 succinic acid Substances 0.000 claims description 15
- 235000000346 sugar Nutrition 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 12
- 241000186216 Corynebacterium Species 0.000 claims description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 230000036647 reaction Effects 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 241000186254 coryneform bacterium Species 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 14
- 241001148470 aerobic bacillus Species 0.000 abstract description 8
- 230000001580 bacterial effect Effects 0.000 abstract description 6
- 150000001720 carbohydrates Chemical class 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 14
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 241000186146 Brevibacterium Species 0.000 description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 description 5
- 230000005526 G1 to G0 transition Effects 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 229910000160 potassium phosphate Inorganic materials 0.000 description 5
- 235000011009 potassium phosphates Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 241000319304 [Brevibacterium] flavum Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 3
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 3
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 3
- 125000001477 organic nitrogen group Chemical group 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000186031 Corynebacteriaceae Species 0.000 description 2
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 2
- 235000000638 D-biotin Nutrition 0.000 description 2
- 239000011665 D-biotin Substances 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、好気性細菌を用い
た有機酸の製造に関するものである。TECHNICAL FIELD The present invention relates to the production of organic acids using aerobic bacteria.
【0002】[0002]
【従来の技術】コハク酸などを発酵により生産する場
合、通常、アネロビオスピリルム(Anaerobiospirillu
m)属、アクチノバチルス(Actinobacillus)属等の嫌
気性細菌が用いられている。嫌気性細菌を用いた場合
は、生産物の収率が高いが、一方で増殖するために多く
の栄養素を要求するために、培地中に多量のCSLなど
の有機窒素源を添加する必要がある。これらの有機窒素
源の多量の添加は培地コストの上昇をもたらすだけでな
く、生産物を取り出す際の精製コストの上昇にもつなが
り経済的でない。2. Description of the Related Art In the case of producing succinic acid and the like by fermentation, it is usual to use Anaerobiospirillu.
Anaerobic bacteria such as genus m) and genus Actinobacillus are used. When anaerobic bacteria are used, the yield of the product is high, but on the other hand, it is necessary to add a large amount of an organic nitrogen source such as CSL to the medium because it requires a large amount of nutrients to grow. . Addition of a large amount of these organic nitrogen sources not only leads to an increase in culture medium cost, but also leads to an increase in purification cost when the product is taken out, which is not economical.
【0003】また、好気性細菌を好気性条件下で一度培
養し、菌体を増殖させた後、集菌、洗浄し、これを静止
菌体として用い、酸素を通気せずに有機酸を生産する方
法も知られている。この場合、菌体を増殖させるに当た
っては、有機窒素の添加量が少なくてよく、簡単な培地
で十分増殖できるため経済的ではあるが、目的とする有
機酸の生成量や菌体当たりの生産速度は未だ不十分であ
り、より優れた方法の確立が望まれていた。Further, aerobic bacteria are once cultivated under aerobic conditions to grow the cells, which are then collected and washed and used as stationary cells to produce organic acids without aeration of oxygen. It is also known how to do it. In this case, when growing cells, it is economical to add a small amount of organic nitrogen and sufficient growth can be achieved with a simple medium, but it is economical, but the production amount of the target organic acid and the production rate per cell are high. Is still insufficient, and establishment of a better method was desired.
【0004】[0004]
【発明が解決しようとする課題】本発明の課題は、より
発酵効率の高い有機酸の製造方法を提供することにあ
る。An object of the present invention is to provide a method for producing an organic acid having higher fermentation efficiency.
【0005】[0005]
【課題を解決するための手段】本発明者は、上記課題を
解決するために鋭意検討を行った結果、原料とする糖質
の濃度を特定の範囲に制御することにより、生産速度及
び収率を下げずに、生産物を高濃度に蓄積させることが
できることを見出し、本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies to solve the above problems, the present inventor has found that the production rate and the yield can be controlled by controlling the concentration of sugar as a raw material within a specific range. The inventors have found that the product can be accumulated at a high concentration without lowering the temperature, and have completed the present invention.
【0006】すなわち本発明の要旨は、好気性細菌の菌
体反応により有機酸を製造するに当たり、培養液中の原
料糖質の最大濃度が10.5%以上25%未満で培養す
ることを特徴とする有機酸の製造方法に存する。That is, the gist of the present invention is that when an organic acid is produced by a microbial cell reaction of an aerobic bacterium, the culture is performed at a maximum concentration of raw sugar of 10.5% or more and less than 25%. And a method for producing an organic acid.
【0007】[0007]
【発明の実施の形態】以下、発明を詳細に説明する。本
発明に使用される細菌は、有機酸の生産能を有すれば特
に限定されないが、このうち、バチルス(Bacillus)
属、リゾビウム(Rizobium)属、コリネバクテリウム
(Corynebacterium)属、ブレビバクテリウム(Breviba
cterium)属、アースロバクター(Arthrobacter)属に
属する微生物等の好気性細菌が好ましい。BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below. The bacterium used in the present invention is not particularly limited as long as it has the ability to produce organic acids. Among them, Bacillus
Genus, Rizobium, Corynebacterium, Breviba
Aerobic bacteria such as microorganisms belonging to the genus cterium and the genus Arthrobacter are preferable.
【0008】上記好気性細菌のうち好ましくはコリネ型
細菌であり、該コリネ型細菌として好ましくは、コリネ
バクテリウム属に属する微生物、ブレビバクテリウム属
に属する微生物又はアースロバクター属に属する微生物
が挙げられ、このうち好ましくは、コリネバクテリウム
属又はブレビバクテリウム属に属するものが挙げられ、
更に好ましくは、コリネバクテリウム グルタミカム
(Corynebacterium glutamic
um)、ブレビバクテリウム フラバム(Brevib
acterium flavum)、ブレビバクテリウ
ムアンモニアゲネスBrevibacterium a
mmoniagenes)又はブレビバクテリウム ラ
クトファーメンタム(Brevibacterium
lactofermentum)に属する微生物が挙げ
られる。Of the above aerobic bacteria, coryneform bacteria are preferred, and the coryneform bacteria are preferably microorganisms belonging to the genus Corynebacterium, microorganisms belonging to the genus Brevibacterium or microorganisms belonging to the genus Arthrobacter. Among them, preferably, those belonging to the genus Corynebacterium or the genus Brevibacterium,
More preferably, Corynebacterium glutamicum (Corynebacterium glutamic)
um), Brevibacterium flavum (Brevib)
Activum flavum), Brevibacterium ammoniagenes Brevibacterium a
mmoniagenes) or Brevibacterium lactofermentum (Brevibacterium)
Lactofermentum).
【0009】上記微生物の特に好ましい具体例として
は、ブレビバクテリウム フラバム(Brevibac
terium flavum)MJ−233(FERM
BP−1497)、同MJ−233AB−41(FE
RM BP−1498)、ブレビバクテリウム アンモ
ニアゲネス(Brevibacterium ammo
niagenes) ATCC6872、コリネバクテ
リウム グルタミカム(Corynebacteriu
m glutamicum) ATCC31831、ブ
レビバクテリウム ラクトファーメンタム(Brevi
bacterium lactofermentum)
ATCC13869が挙げられる。As a particularly preferred specific example of the above-mentioned microorganism, Brevibacterium flavum (Brevibac)
terium flavum) MJ-233 (FERM
BP-1497), the same MJ-233AB-41 (FE
RM BP-1498), Brevibacterium ammoniagenes (Brevibacterium ammo)
niagenes) ATCC 6872, Corynebacterium glutamicum (Corynebacterium)
m glutamicum) ATCC31831, Brevibacterium lactofermentum (Brevi
Bacterium lactofermentum)
ATCC 13869 may be mentioned.
【0010】本発明の製造方法において用いられる上記
微生物は、野生株だけでなく、UV照射やNTG処理等
の通常の変異処理により得られる変異株、細胞融合もし
くは遺伝子組換え法などの遺伝学的手法により誘導され
る組換え株などのいずれの株であってもよい。尚、上記
遺伝子組み換え株の宿主としては、形質転換可能な微生
物であれば、親株と同じ属種であっても良いし、属種の
異なるものであっても良いが、上述のような好気性細菌
を宿主とするのが好ましい。The above-mentioned microorganisms used in the production method of the present invention are not only wild strains but also mutant strains obtained by ordinary mutation treatment such as UV irradiation and NTG treatment, and genetics such as cell fusion or gene recombination method. Any strain such as a recombinant strain derived by the method may be used. The host of the genetically modified strain may be the same genus species as the parent strain or different genus species as long as it is a transformable microorganism. It is preferable to use bacteria as a host.
【0011】このうち、本反応においては、乳酸脱水素
酵素の欠如した変異株を用いるとより有効である。コリ
ネ型細菌の乳酸脱水素酵素の欠如した変異株の具体的な
製造方法としては、特開平11−205385号公報に
記載されている方法が挙げられ、これに準じて簡単に作
成できる。本反応に上記細菌を用いるに当たっては、寒
天培地等の固体培地で斜面培養したものを直接反応に用
いても良いが、上記細菌を予め液体培地で培養(種培
養)したものを用いるのが好ましい。Among these, in this reaction, it is more effective to use a mutant strain lacking lactate dehydrogenase. As a specific method for producing the mutant strain of coryneform bacterium lacking lactate dehydrogenase, the method described in JP-A No. 11-205385 can be mentioned, which can be easily prepared in accordance with this method. When using the bacterium in the present reaction, it is possible to use the one that is slant-cultured in a solid medium such as agar medium for the direct reaction, but it is preferable to use the one that is previously cultivated (seed culture) in the liquid medium. .
【0012】これらの細菌を培養するために使用される
培地の主炭素源としては、本微生物が資化しうる炭素源
であれば特に限定されないが、通常、ガラクトース、ラ
クトース、グルコース、フルクトース、グリセロール、
シュークロース、サッカロース、デンプン、セルロース
等の炭水化物;グリセリン、マンニトール、キシリトー
ル、リビトール等のポリアルコール類等の発酵性糖質が
用いられ、このうちグルコース、フルクトース、グリセ
ロールが好ましく、特にグルコースが好ましい。[0012] The main carbon source of the medium used for culturing these bacteria is not particularly limited as long as it is a carbon source that can be assimilated by the present microorganism, but usually galactose, lactose, glucose, fructose, glycerol,
Carbohydrates such as sucrose, sucrose, starch, and cellulose; fermentable sugars such as polyalcohols such as glycerin, mannitol, xylitol, and ribitol are used. Of these, glucose, fructose, and glycerol are preferable, and glucose is particularly preferable.
【0013】また、上記発酵性糖質を含有する澱粉糖化
液、糖蜜なども使用される。これらの発酵性糖質は、単
独でも組み合わせても使用できる。本反応においては、
上記糖類の最大濃度を25%(W/V)未満、好ましく
は20%(W/V)以下とする。一方で、原料糖質の濃
度が低すぎると、工業生産時の釜効率等の点で好ましく
ないため、通常、10.5%(W/V)以上、好ましく
は11%(W/V)以上で反応を行う。Further, starch saccharified solution, molasses and the like containing the above fermentable sugar are also used. These fermentable sugars can be used alone or in combination. In this reaction,
The maximum concentration of the saccharide is less than 25% (W / V), preferably 20% (W / V) or less. On the other hand, if the concentration of the raw material sugar is too low, it is not preferable in terms of the pot efficiency during industrial production. Therefore, it is usually 10.5% (W / V) or more, preferably 11% (W / V) or more. To react.
【0014】また、最大濃度が25%(W/V)を越え
なければ、反応の進行に伴い、上記糖類を追加添加をす
るのも生産物の蓄積量の向上のためには好ましい。窒素
源としては、本微生物が資化しうる炭素源であれば特に
限定されないが、具体的には、アンモニウム塩、硝酸
塩、尿素、大豆加水分解物、カゼイン分解物、ペプト
ン、酵母エキス、肉エキス、コーンスティープリカーな
どの各種の有機、無機の窒素化合物が挙げられる。Further, if the maximum concentration does not exceed 25% (W / V), it is also preferable to add the above-mentioned saccharides as the reaction progresses, in order to improve the accumulated amount of the product. The nitrogen source is not particularly limited as long as it is a carbon source that the microorganism can assimilate, but specifically, ammonium salt, nitrate, urea, soybean hydrolyzate, casein hydrolyzate, peptone, yeast extract, meat extract, Examples include various organic and inorganic nitrogen compounds such as corn steep liquor.
【0015】無機塩としては各種リン酸塩、硫酸塩、マ
グネシウム、カリウム、マンガン、鉄、亜鉛等の金属塩
が用いられる。また、ビオチン、パントテン酸、イノシ
トール、ニコチン酸等のビタミン類、ヌクレオチド、ア
ミノ酸などの生育を促進する因子を必要に応じて添加す
る。また、反応時の発泡を抑えるために、培養液には市
販の消泡剤を適量添加しておくことが望ましい。As the inorganic salt, various phosphates, sulfates, metal salts such as magnesium, potassium, manganese, iron and zinc are used. In addition, factors that promote the growth of vitamins such as biotin, pantothenic acid, inositol and nicotinic acid, nucleotides and amino acids are added as necessary. Further, in order to suppress foaming during the reaction, it is desirable to add an appropriate amount of a commercially available antifoaming agent to the culture solution.
【0016】培養液のpHは、通常、pH5〜9、好ま
しくはpH6.5〜8.5に調整し、反応中も必要に応
じて培養液のpHはアルカリ性物質、炭酸塩、尿素など
によって上記範囲内に調節する。本反応においては、好
気性細菌を用いるため、菌体の生育に酸素が必要とな
る。一方で、本反応においては、培養液と菌体を接触さ
せた後、まず菌体が対数増殖した後に定常期を迎える。
従って、対数増殖期か定常期かで必要とする酸素量も変
化するので、反応のスケールや羽形状の違いによる攪拌
効率の違いを考慮した上で、通気量や攪拌量を調整する
必要がある。The pH of the culture broth is usually adjusted to pH 5 to 9, preferably pH 6.5 to 8.5, and the pH of the culture broth may be adjusted with alkaline substances, carbonates, urea, etc., if necessary during the reaction. Adjust within the range. Since aerobic bacteria are used in this reaction, oxygen is required for the growth of bacterial cells. On the other hand, in this reaction, after contacting the culture solution with the bacterial cells, the bacterial cells first undergo logarithmic growth and then reach a stationary phase.
Therefore, the amount of oxygen required also changes during the logarithmic growth phase or stationary phase, so it is necessary to adjust the aeration rate and stirring rate after considering the difference in stirring efficiency due to the difference in reaction scale and blade shape. .
【0017】本発明の方法においては、反応温度は通常
の、菌体反応が行われる範囲であれば、特に限定されな
いが、菌体の生育が定常期に達した以降の反応温度を当
該細菌の生育至適温度より高い温度とするのが好まし
く、上記対数増殖期の温度を菌体の生育至適温度±2℃
の温度とし、定常期に達した以降に該温度より温度を上
昇させて反応を行うことがより好ましい。ここで定常期
以降の温度は、対数増殖期の温度より2〜10℃上昇さ
せた温度が特に好ましい。In the method of the present invention, the reaction temperature is not particularly limited as long as it is within a range where the microbial cell reaction is carried out, but the reaction temperature after the microbial cell growth reaches the stationary phase is set to that of the bacterium. It is preferable that the temperature is higher than the optimum growth temperature, and the temperature in the logarithmic growth phase is the optimum growth temperature of the bacterial cells ± 2 ° C.
It is more preferable to carry out the reaction at a temperature of, and after the stationary phase is reached, the temperature is raised above the temperature. Here, the temperature after the stationary phase is particularly preferably a temperature increased by 2 to 10 ° C. from the temperature in the logarithmic growth phase.
【0018】本反応に用いる微生物の生育至適温度は、
通常、25℃〜35℃である。本反応は、通常、培養液
中の原料糖質が消費された時点で反応終了とする。この
とき、反応液中には、リンゴ酸、フマル酸、コハク酸等
の有機酸が生成している。このうち、コハク酸がもっと
も蓄積度が高く生産物としては好ましい。このようにし
て培養液中に蓄積した有機酸は常法に従って、培養液よ
り分離・精製される。具体的には、遠心分離、ろ過等に
より菌体等の固形物を除去した後、イオン交換樹脂等で
脱塩し、その溶液から結晶化あるいはカラムクロマトグ
ラフィーにより有機酸を分離・精製することができる。The optimum temperature for growth of the microorganism used in this reaction is
Usually, it is 25 ° C to 35 ° C. This reaction is usually terminated when the raw sugar in the culture medium is consumed. At this time, organic acids such as malic acid, fumaric acid, and succinic acid are generated in the reaction solution. Of these, succinic acid has the highest degree of accumulation and is preferred as a product. The organic acid thus accumulated in the culture broth is separated and purified from the culture broth according to a conventional method. Specifically, after removing solid matter such as bacterial cells by centrifugation, filtration, etc., desalting with an ion exchange resin etc., the organic acid can be separated and purified from the solution by crystallization or column chromatography. it can.
【0019】[0019]
【実施例】以下に、実施例を挙げて本発明を更に詳細に
説明するが、本発明はこれらの実施例により制限される
ものではない。
実施例1
ブレビバクテリウム・フラバムMJ233AB―41
(FERM BP−1498)から特開平11−206
385に従い、乳酸脱水素酵素(LDH)の欠如した株
を調整した。すなわち、MJ233AB―41株より常
法により抽出した全DNAを鋳型として当該特許に配列
番号5及び6として記載された2つのプライマーを用い
て、ラクテートデヒドロゲナーゼ遺伝子の部分断片につ
いてPCR反応を行った。得られた反応液3μlとPC
R産物用のクローニングベクターpGEM−T(PRO
MEGA社製)1μlとを混合し、50mMトリス緩衝
液(pH7.6)、10mMジチオスレイトール、1m
M ATP、10mM MgCl2及びT4DNAリガ
ーゼ1unitsの各成分を添加し、4℃で15時間反
応させ、結合させた。得られたプラスミド混液を用い、
塩化カルシウム法によりエシェリヒア・コリJM109
(宝酒造製)を形質転換し、アンピシリン50mgを含
む培地(トリプトン10g、イーストエキストラクト5
g、NaCl5g及び寒天16gを蒸留水1Lに溶解)
に塗布した。この培地上の生育株を常法により液体培養
し、培養液よりプラスミドDNAを調整した。このプラ
スミドDNA20μlに、50mM トリス緩衝液(p
H7.5)、1mMジチオスレイトール、10mM M
gCl2、100mM NaCl、制限酵素SphI及
びSalI 1unitの各成分を添加し、37℃で1
時間反応させた。得られたDNA溶液からGene C
leanII(フナコシ社製)を用いて300bp断片の
回収を行い、該DNA溶液10μlと、クロラムフェニ
コール耐性のクローニングベクターpHSG396(宝
酒造製)1μlのSphI及びSalI分解物と混合
し、50mMトリス緩衝液(pH7.6)、10mMジ
チオスレイトール、1mM ATP、10mM MgC
l2及びT4DNAリガーゼ1unitsの各成分を添
加し、4℃で15時間反応させ、結合させた。得られた
プラスミド混液を用い、塩化カルシウム法によりエシェ
リヒア・コリJM109(宝酒造製)を形質転換し、ア
ンピシリン50mgを含む培地(トリプトン10g、イ
ーストエキストラクト5g、NaCl5g及び寒天16
gを蒸留水1Lに溶解)に塗布した。この培地上の生育
株を常法により液体培養し、培養液より上記ラクテート
デヒドロゲナーゼ遺伝子の部分断片である約300bp
の断片が導入されたプラスミドDNAを調整した。該プ
ラスミドを電気パルス法によりブレビバクテリウム・フ
ラバムMJ233AB―41に導入し、クロラムフェニ
コール5mgを含む培地(尿素:2g、硫酸アンモニウ
ム:7g、リン酸1カリウム:0.5g、リン酸2カリ
ウム0.5g、硫酸マグネシウム・7水和物:0.5
g、硫酸第一鉄・7水和物:20mg、硫酸マンガン・
水和物:20mg、D−ビオチン:200μg、塩酸チ
アミン:200μg、酵母エキス:1g、カザミノ酸:
1g、及び寒天16gを蒸留水1Lに溶解)に塗布し
た。この培地上で生育してきた菌株の内、相同組み換え
により該遺伝子が破壊された株として、LDH活性が1
0分の1以下になった株を選抜した。The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples. Example 1 Brevibacterium flavum MJ233AB-41
(FERM BP-1498) to JP-A-11-206
According to 385, strains lacking lactate dehydrogenase (LDH) were prepared. That is, a PCR reaction was carried out on a partial fragment of the lactate dehydrogenase gene using the total DNA extracted from the MJ233AB-41 strain by a conventional method as a template and two primers described as SEQ ID NOS: 5 and 6 in the patent. 3 μl of the obtained reaction solution and PC
Cloning vector pGEM-T (PRO for R products
MEGA) 1 μl, and mixed with 50 mM Tris buffer (pH 7.6), 10 mM dithiothreitol, 1 m
Each component of M ATP, 10 mM MgCl 2 and 1 unit of T4 DNA ligase was added and allowed to react at 4 ° C. for 15 hours for binding. Using the obtained plasmid mixture,
Escherichia coli JM109 by calcium chloride method
(Takara Shuzo) was transformed and a medium containing 50 mg of ampicillin (10 g of tryptone, 5 yeast extract).
g, NaCl 5 g and agar 16 g dissolved in 1 L of distilled water)
Was applied to. The strain grown on this medium was liquid-cultured by a conventional method, and plasmid DNA was prepared from the culture medium. 20 μl of this plasmid DNA was added to 50 mM Tris buffer (p
H7.5), 1 mM dithiothreitol, 10 mM M
Add each component of gCl 2 , 100 mM NaCl, restriction enzymes SphI and SalI 1 unit, and add 1 at 37 ° C.
Reacted for hours. Gene C from the obtained DNA solution
A 300 bp fragment was recovered using leanII (manufactured by Funakoshi), mixed with 10 μl of the DNA solution and 1 μl of a chloramphenicol-resistant cloning vector pHSG396 (Takara Shuzo Co., Ltd.) decomposed with SphI and SalI to obtain a 50 mM Tris buffer. (PH 7.6), 10 mM dithiothreitol, 1 mM ATP, 10 mM MgC
Each component of 12 and T4 DNA ligase 1 units was added and reacted at 4 ° C. for 15 hours to bind. Using the resulting plasmid mixture, Escherichia coli JM109 (Takara Shuzo) was transformed by the calcium chloride method, and a medium containing 50 mg of ampicillin (tryptone 10 g, yeast extract 5 g, NaCl 5 g and agar 16).
g was dissolved in 1 L of distilled water). The strain grown on this medium is liquid-cultured by a conventional method, and about 300 bp, which is a partial fragment of the lactate dehydrogenase gene, is obtained from the culture.
The plasmid DNA into which the fragment was introduced was prepared. The plasmid was introduced into Brevibacterium flavum MJ233AB-41 by the electric pulse method, and the medium containing 5 mg of chloramphenicol (urea: 2 g, ammonium sulfate: 7 g, potassium phosphate 1: 0.5 g, potassium phosphate 0: 0.5 g, magnesium sulfate heptahydrate: 0.5
g, ferrous sulfate heptahydrate: 20 mg, manganese sulfate
Hydrate: 20 mg, D-biotin: 200 μg, thiamine hydrochloride: 200 μg, yeast extract: 1 g, casamino acid:
1 g and 16 g of agar were dissolved in 1 L of distilled water). Among the strains grown on this medium, LDH activity was 1 as a strain in which the gene was disrupted by homologous recombination.
Strains that became less than 1/0 were selected.
【0020】尿素:4g、硫酸アンモニウム:14g、
リン酸1カリウム:0.5g、リン酸2カリウム0.5
g、硫酸マグネシウム・7水和物:0.5g、硫酸第一
鉄・7水和物:20mg、硫酸マンガン・水和物:20
mg、D−ビオチン:200μg、塩酸チアミン:20
0μg、酵母エキス:1g、カザミノ酸:1g、及び蒸
留水:1000mlの培地を100mLを500mLの
三角フラスコにいれ、120℃、20分加熱滅菌した。
これを室温まで冷やし、あらかじめ滅菌した50%グル
コース水溶液を4ml、無菌濾過した0.1%クロラム
フェニコール水溶液を5ml添加し、前述のラクテート
デヒドロゲナーゼ遺伝子破壊株を接種して24時間30
℃にて種培養した。Urea: 4 g, ammonium sulfate: 14 g,
1 potassium phosphate: 0.5 g, 2 potassium phosphate 0.5
g, magnesium sulfate heptahydrate: 0.5 g, ferrous sulfate heptahydrate: 20 mg, manganese sulfate hydrate: 20
mg, D-biotin: 200 μg, thiamine hydrochloride: 20
100 mL of a medium containing 0 μg, yeast extract: 1 g, casamino acid: 1 g, and distilled water: 1000 ml was put in a 500 mL Erlenmeyer flask and sterilized by heating at 120 ° C. for 20 minutes.
This was cooled to room temperature, 4 ml of 50% glucose aqueous solution that had been sterilized in advance and 5 ml of 0.1% chloramphenicol aqueous solution that had been sterile filtered were added, and the lactate dehydrogenase gene-disrupted strain was inoculated for 24 hours and 30 hours.
Seed culture was performed at ° C.
【0021】尿素:8g、硫酸アンモニウム:28g、
リン酸1カリウム:1g、リン酸2カリウム1g、硫酸
マグネシウム・7水和物:1g、硫酸第一鉄・7水和
物:40mg、硫酸マンガン・水和物:40mg、D−
ビオチン:400μg、塩酸チアミン:400μg、酵
母エキス2g、カザミノ酸2g、消泡剤(アデカノール
LG294:旭電化製):1ml及び蒸留水:1000
mlの培地を5Lの発酵糟に入れ、120℃、20分加
熱滅菌した。これを室温まで冷やした後に、あらかじめ
滅菌した22%グルコース水溶液1000mlを添加し
て系内のグルコース濃度を11%としたものに、前述の
種培養液を全量加えて、30℃に保温した。pHは2M
炭酸ナトリウムで8.0に保ち、通気は毎分400m
L、攪拌は毎分300回転で反応を行った。反応開始
後、25時間後にグルコースがほぼ消費されており、コ
ハク酸が37g/L蓄積していた。このときのコハク酸の
対糖収率は53%、生産速度は1.40g/L/hrで
あった。Urea: 8 g, ammonium sulfate: 28 g,
Potassium phosphate 1 g, dipotassium phosphate 1 g, magnesium sulfate heptahydrate: 1 g, ferrous sulfate heptahydrate: 40 mg, manganese sulfate hydrate: 40 mg, D-
Biotin: 400 μg, thiamine hydrochloride: 400 μg, yeast extract 2 g, casamino acid 2 g, antifoaming agent (Adecanol LG294: manufactured by Asahi Denka): 1 ml and distilled water: 1000
5 ml of fermentation broth was added with ml of medium, and sterilized by heating at 120 ° C for 20 minutes. After cooling this to room temperature, 1000 ml of a previously sterilized 22% glucose aqueous solution was added to make the glucose concentration in the system 11%, and the above seed culture solution was added in total to keep it at 30 ° C. pH is 2M
Maintained at 8.0 with sodium carbonate, aeration is 400m / min
The reaction was performed at L and stirring at 300 rpm. After 25 hours from the start of the reaction, glucose was almost consumed and succinic acid was accumulated at 37 g / L. At this time, the yield of succinic acid with respect to sugar was 53%, and the production rate was 1.40 g / L / hr.
【0022】実施例2
添加するグルコースの濃度を30%に変えた、すなわ
ち、系内のグルコース濃度を15%とした以外は実施例
1と同様に行ったところ、35時間後にグルコースがほ
ぼ消費されており、コハク酸が48g/L蓄積していた。
このときのコハク酸の対糖収率は55%、生産速度は
1.37g/L/hrであった。Example 2 The procedure of Example 1 was repeated except that the concentration of glucose to be added was changed to 30%, that is, the glucose concentration in the system was changed to 15%, and glucose was almost consumed after 35 hours. Succinic acid was accumulated at 48 g / L.
At this time, the yield of succinic acid with respect to sugar was 55%, and the production rate was 1.37 g / L / hr.
【0023】実施例3
添加するグルコースの濃度を40%に変えた、すなわ
ち、系内のグルコース濃度を20%とした以外は実施例
1と同様に行ったところ、48時間後にグルコースがほ
ぼ消費されており、コハク酸が65g/L蓄積していた。
このときのコハク酸の対糖収率は60%、生産速度は
1.35g/L/hrであった。Example 3 The procedure of Example 1 was repeated except that the concentration of glucose to be added was changed to 40%, that is, the glucose concentration in the system was changed to 20%, and glucose was almost consumed after 48 hours. And 65 g / L of succinic acid was accumulated.
At this time, the yield of succinic acid with respect to sugar was 60%, and the production rate was 1.35 g / L / hr.
【0024】比較例1
添加するグルコースの濃度を50%に変えた、すなわ
ち、系内のグルコース濃度を25%とした以外は実施例
1と同様に行ったところ、85時間後にグルコースがほ
ぼ消費されており、コハク酸が72g/L蓄積していた。
このときのコハク酸の対糖収率は54%、生産速度は
1.04g/L/hrであった。COMPARATIVE EXAMPLE 1 The procedure of Example 1 was repeated except that the concentration of glucose to be added was changed to 50%, that is, the glucose concentration in the system was changed to 25%, and glucose was almost consumed after 85 hours. And 72 g / L of succinic acid was accumulated.
At this time, the yield of succinic acid with respect to sugar was 54%, and the production rate was 1.04 g / L / hr.
【0025】比較例2
添加するグルコースの濃度を10%に変えた、すなわ
ち、系内のグルコース濃度を5%とした以外は実施例1
と同様に行った。18時間後、グルコースがほぼ消費さ
れており、コハク酸が18g/L蓄積していた。このとき
のコハク酸の対糖収率は40%、生成速度は1.03g
/L/hrComparative Example 2 Example 1 except that the concentration of glucose added was changed to 10%, that is, the glucose concentration in the system was changed to 5%.
I went the same way. After 18 hours, glucose was almost consumed and succinic acid was accumulated at 18 g / L. At this time, the yield of succinic acid based on sugar was 40%, and the production rate was 1.03 g.
/ L / hr
【0026】[0026]
【発明の効果】本発明の方法によれば、好気性細菌を用
いた有機酸の製造において、高い反応速度及び収率で目
的物を得ることができる。EFFECTS OF THE INVENTION According to the method of the present invention, the target substance can be obtained at a high reaction rate and a high yield in the production of organic acid using aerobic bacteria.
Claims (8)
造するに当たり、培養液中の原料糖質の最大濃度が1
0.5%以上25%未満で培養することを特徴とする有
機酸の製造方法。1. When producing an organic acid by a microbial cell reaction of an aerobic bacterium, the maximum concentration of raw sugar in a culture solution is 1
A method for producing an organic acid, which comprises culturing at 0.5% or more and less than 25%.
未満であることを特徴とする請求項1に記載の製造方
法。2. The maximum concentration of raw sugar is 11% or more and 25%.
It is less than, The manufacturing method of Claim 1 characterized by the above-mentioned.
とする請求項1又は2に記載の製造方法。3. The production method according to claim 1, wherein the raw material sugar is glucose.
酸であることを特徴とする請求項1〜3のいずれかに記
載の有機酸の製造方法。4. The method for producing an organic acid according to claim 1, wherein the organic acid is malic acid, fumaric acid or succinic acid.
る請求項4に記載の有機酸の製造方法。5. The method for producing an organic acid according to claim 4, wherein the organic acid is succinic acid.
特徴とする請求項1〜5のいずれかに記載の有機酸の製
造方法。6. The method for producing an organic acid according to claim 1, wherein the aerobic bacterium is a coryneform bacterium.
する細菌であることを特徴とする請求項1〜5のいずれ
かに記載の有機酸の製造方法。7. The method for producing an organic acid according to claim 1, wherein the aerobic bacterium is a bacterium belonging to the genus Corynebacterium.
酸生産能が90%以上低下した変異株であることを特徴
とした請求項1〜7に記載の有機酸の製造方法。8. The method for producing an organic acid according to claim 1, wherein the aerobic bacterium is a mutant strain in which the lactic acid-producing ability of the bacterium is 90% or more lower than that of the wild type.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002034825A JP2003235592A (en) | 2002-02-13 | 2002-02-13 | Organic acid production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002034825A JP2003235592A (en) | 2002-02-13 | 2002-02-13 | Organic acid production method |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003235592A true JP2003235592A (en) | 2003-08-26 |
Family
ID=27777186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002034825A Pending JP2003235592A (en) | 2002-02-13 | 2002-02-13 | Organic acid production method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003235592A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005021770A1 (en) * | 2003-08-28 | 2005-03-10 | Mitsubishi Chemical Corporation | Process for producing succinic acid |
WO2005026349A1 (en) * | 2003-09-17 | 2005-03-24 | Mitsubishi Chemical Corporation | Process for producing non-amino organic acid |
JP2006197821A (en) * | 2005-01-18 | 2006-08-03 | Research Institute Of Innovative Technology For The Earth | Highly efficient production method of organic acid by aerobic bacteria |
EP1760143A4 (en) * | 2004-05-20 | 2007-06-27 | Ajinomoto Kk | BACTERIA PRODUCING SUCCINIC ACID AND PROCESS FOR PRODUCING SUCCINIC ACID |
WO2008126896A1 (en) | 2007-04-10 | 2008-10-23 | Ajinomoto Co., Inc. | Method for production of organic acid |
US7829316B2 (en) | 2005-10-18 | 2010-11-09 | Ajinomoto Co., Inc. | Process for production of succinic acid |
US7833763B2 (en) | 2003-07-09 | 2010-11-16 | Mitsubishi Chemical Corporation | Method for producing organic acid |
US7993888B2 (en) | 2006-02-24 | 2011-08-09 | Mitsubishi Chemical Corporation | Bacterium having enhanced 2-oxoglutarate dehydrogenase activity |
JP2012510971A (en) * | 2008-12-04 | 2012-05-17 | ロディア オペレーションズ | Process for producing a compound having a nitrile group |
EP2484771A1 (en) | 2007-03-19 | 2012-08-08 | Sumitomo Chemical Company Limited | Process for producing D-lactic acid from glycerol employing Serratia marcescens |
US8647843B2 (en) | 2010-03-09 | 2014-02-11 | Mitsubishi Chemical Corporation | Method of producing succinic acid |
DE102017101220A1 (en) * | 2017-01-23 | 2018-07-26 | Thyssenkrupp Ag | Minimal medium for the fermentative conversion of mono- and / or disaccharides to lactic acid with Bacillus coagulans strains |
-
2002
- 2002-02-13 JP JP2002034825A patent/JP2003235592A/en active Pending
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7833763B2 (en) | 2003-07-09 | 2010-11-16 | Mitsubishi Chemical Corporation | Method for producing organic acid |
WO2005021770A1 (en) * | 2003-08-28 | 2005-03-10 | Mitsubishi Chemical Corporation | Process for producing succinic acid |
US7763447B2 (en) | 2003-08-28 | 2010-07-27 | Ajinomoto Co., Inc. | Method of producing succinic acid with bacterium comprising a modified fumarate reductase gene or a modified succinate dehydrogenase gene |
WO2005026349A1 (en) * | 2003-09-17 | 2005-03-24 | Mitsubishi Chemical Corporation | Process for producing non-amino organic acid |
JPWO2005026349A1 (en) * | 2003-09-17 | 2007-11-08 | 三菱化学株式会社 | Method for producing non-amino organic acid |
US7563606B2 (en) | 2003-09-17 | 2009-07-21 | Mitsubishi Chemical Corporation | Method for producing non-amino organic acid |
JP4619291B2 (en) * | 2003-09-17 | 2011-01-26 | 三菱化学株式会社 | Method for producing non-amino organic acid |
EP1760143A4 (en) * | 2004-05-20 | 2007-06-27 | Ajinomoto Kk | BACTERIA PRODUCING SUCCINIC ACID AND PROCESS FOR PRODUCING SUCCINIC ACID |
JP5023701B2 (en) * | 2004-05-20 | 2012-09-12 | 味の素株式会社 | Succinic acid-producing bacteria and method for producing succinic acid |
US7972823B2 (en) | 2004-05-20 | 2011-07-05 | Ajinomoto Co., Inc. | Succinic acid-producing bacterium and process for producing succinic acid |
JP2006197821A (en) * | 2005-01-18 | 2006-08-03 | Research Institute Of Innovative Technology For The Earth | Highly efficient production method of organic acid by aerobic bacteria |
US7829316B2 (en) | 2005-10-18 | 2010-11-09 | Ajinomoto Co., Inc. | Process for production of succinic acid |
US7993888B2 (en) | 2006-02-24 | 2011-08-09 | Mitsubishi Chemical Corporation | Bacterium having enhanced 2-oxoglutarate dehydrogenase activity |
EP2484771A1 (en) | 2007-03-19 | 2012-08-08 | Sumitomo Chemical Company Limited | Process for producing D-lactic acid from glycerol employing Serratia marcescens |
EP2487247A1 (en) | 2007-03-19 | 2012-08-15 | Sumitomo Chemical Co., Ltd. | Process for producing D-lactic acid from glycerol employing Frateuria aurantia |
EP2492348A1 (en) | 2007-03-19 | 2012-08-29 | Sumitomo Chemical Company Limited | Process for producing D-lactic acid from glycerol employing Pseudomonas auricularis, Pseudomonas azotoformans, Pseudomonas chlororaphis, Pseudomonas taetrolens, or Pseuomonas sp. |
EP2492350A1 (en) | 2007-03-19 | 2012-08-29 | Sumitomo Chemical Co., Ltd. | Process for producing D-lactic acid from glycerol employing Brevibacterium butanicum |
EP2492349A1 (en) | 2007-03-19 | 2012-08-29 | Sumitomo Chemical Company Limited | Process for producing D-lactic acid from glycerol employing Achromobacter denitrificans |
EP2495330A1 (en) | 2007-03-19 | 2012-09-05 | Sumitomo Chemical Co., Ltd. | Process for producing D-lactic acid from glycerol employing Escherichia coli ATCC 700926 |
WO2008126896A1 (en) | 2007-04-10 | 2008-10-23 | Ajinomoto Co., Inc. | Method for production of organic acid |
JP2012510971A (en) * | 2008-12-04 | 2012-05-17 | ロディア オペレーションズ | Process for producing a compound having a nitrile group |
US8647843B2 (en) | 2010-03-09 | 2014-02-11 | Mitsubishi Chemical Corporation | Method of producing succinic acid |
DE102017101220A1 (en) * | 2017-01-23 | 2018-07-26 | Thyssenkrupp Ag | Minimal medium for the fermentative conversion of mono- and / or disaccharides to lactic acid with Bacillus coagulans strains |
DE102017101220B4 (en) * | 2017-01-23 | 2019-03-21 | Thyssenkrupp Ag | Minimal medium for the fermentative conversion of mono- and / or disaccharides to lactic acid with Bacillus coagulans strains |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4469568B2 (en) | Method for producing organic acid | |
JP4619291B2 (en) | Method for producing non-amino organic acid | |
CN101389752B (en) | Bacteria capable of producing organic acids and method for producing organic acids | |
JP4575086B2 (en) | Method for producing succinic acid | |
US20050255567A1 (en) | Mutant glutamine synthetase and method for producing amino acids | |
JP4197754B2 (en) | Method for producing lactic acid or succinic acid | |
JP2003235592A (en) | Organic acid production method | |
JP4032765B2 (en) | Method for producing organic acid | |
US20070015264A1 (en) | Method for producing organic acid ammonium solution | |
JP5034630B2 (en) | Preparation method of organic acid producing microorganism and production method of organic acid | |
EP3296400B1 (en) | Method for producing l-tryptophan using microorganisms of genus escherichia | |
US10815510B2 (en) | Microorganism of the genus Escherichia producing L-tryptophan and method for producing L-tryptophan using the same | |
JP5543488B2 (en) | Corynebacteria with improved 5'-guanosine monophosphate production ability and method for producing 5'-guanosine monophosphate using the same | |
JP3959403B2 (en) | Purification method of organic acid | |
JP4720114B2 (en) | Method for producing oxaloacetic acid or oxaloacetic acid derivative | |
JP4428999B2 (en) | Method for producing non-amino organic acid | |
JP2005295998A (en) | Method for producing organic acid ammonium solution | |
JP2008011714A (en) | Method for producing succinic acid | |
JP2002136293A (en) | Microorganism and method for producing d-lactic acid | |
JP2005065641A (en) | Method for producing non-amino organic acid | |
JP5034395B2 (en) | Organic acid producing bacteria and method for producing organic acid | |
JP5663859B2 (en) | Non-amino organic acid producing bacteria and method for producing non-amino organic acid | |
EP4417696A1 (en) | Corynebacterium glutamicum variant having improved l-lysine production ability and method for producing l-lysine by using same | |
JP4198147B2 (en) | Method for producing organic acid | |
JP2008067627A (en) | Non-amino organic acid producing bacteria and method for producing non-amino organic acid |